Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Certain cannabinoids may help increase hair growth and could be useful for treating hair loss.

Vitamin D helps improve PCOS by aiding insulin function and ovarian health.

TGF-β1 and 2 may play a role in hair loss in AGA.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

Hormonal imbalance contributes to chronic prostatitis and affects male reproductive health.

1,25-(OH)2D3 helps hair grow by blocking certain harmful signals.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

New treatments for male hypogonadism are effective and should be personalized.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

GLP-1 agonists may help treat certain skin conditions.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Oleanolic acid improved hair growth in mice by affecting hair growth pathways and reducing inflammation.

Bicalutamide may help treat female pattern hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

New treatments for male hypogonadism are easier to use and target specific tissues to reduce side effects.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.